|
1
|
Friedenstein AJ, Gorskaja JF and Kulagina
NN: Fibroblast precursors in normal and irradiated mouse
hematopoietic organs. Exp Hematol. 4:267–274. 1976.PubMed/NCBI
|
|
2
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
In ‘t Anker PS, Scherjon SA, Kleijburg-van
der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH:
Isolation of mesenchymal stem cells of fetal or maternal origin
from human placenta. Stem Cells. 22:1338–1345. 2004.
|
|
5
|
In ‘t Anker PS, Scherjon SA, Kleijburg-van
der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE and Kanhai HH:
Amniotic fluid as a novel source of mesenchymal stem cells for
therapeutic transplantation. Blood. 102:1548–1549. 2003.PubMed/NCBI
|
|
6
|
In ‘t Anker PS, Noort WA, Scherjon SA,
Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL,
Beekhuizen W, Willemze R, Kanhai HH and Fibbe WE: Mesenchymal stem
cells in human second-trimester bone marrow, liver, lung, and
spleen exhibit a similar immunophenotype but a heterogeneous
multilineage differentiation potential. Haematologica. 88:845–852.
2003.
|
|
7
|
Fraser JK, Schreiber R, Strem B, Zhu M,
Alfonso Z, Wulur I and Hedrick MH: Plasticity of human adipose stem
cells toward endothelial cells and cardiomyocytes. Nat Clin Pract
Cardiovasc Med. 3(Suppl 1): S33–S37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le Blanc K, Tammik L, Sundberg B,
Haynesworth SE and Ringdén O: Mesenchymal stem cells inhibit and
stimulate mixed lymphocyte cultures and mitogenic responses
independently of the major histocompatibility complex. Scand J
Immunol. 57:11–20. 2003.PubMed/NCBI
|
|
9
|
Potian JA, Aviv H, Ponzio NM, Harrison JS
and Rameshwar P: Veto-like activity of mesenchymal stem cells:
functional discrimination between cellular responses to
alloantigens and recall antigens. J Immunol. 171:3426–3434. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tse WT, Pendleton JD, Beyer WM, Egalka MC
and Guinan EC: Suppression of allogeneic T-cell proliferation by
human marrow stromal cells: implications in transplantation.
Transplantation. 75:389–397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Nicola M, Carlo-Stella C, Magni M,
Milanesi M, Longoni PD, Matteucci P, Grisanti S and Gianni AM:
Human bone marrow stromal cells suppress T- lymphocyte
proliferation induced by cellular or nonspecific mitogenic stimuli.
Blood. 99:3838–3843. 2002.
|
|
12
|
Plumas J, Chaperot L, Richard MJ, Molens
JP, Bensa JC and Favrot MC: Mesenchymal stem cells induce apoptosis
of activated T cells. Leukemia. 19:1597–1604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Djouad F, Plence P, Bony C, Tropel P,
Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive
effect of mesenchymal stem cells favors tumor growth in allogeneic
animals. Blood. 102:3837–3844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Corcione A, Benvenuto F, Ferretti E,
Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi
GL, Pistoia V and Uccelli A: Human mesenchymal stem cells modulate
B-cell functions. Blood. 107:367–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spaggiari GM, Capobianco A, Abdelrazik H,
Becchetti F, Mingari MC and Moretta L: Mesenchymal stem cells
inhibit natural killer-cell proliferation, cytotoxicity, and
cytokine production: role of indoleamine 2,3-dioxygenase and
prostaglandin E2. Blood. 111:1327–1333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
English K, Ryan JM, Tobin L, Murphy MJ,
Barry FP and Mahon BP: Cell contact, prostaglandin E(2) and
transforming growth factor beta 1 play non-redundant roles in human
mesenchymal stem cell induction of
CD4+CD25High forkhead box P3+
regulatory T cells. Clin Exp Immunol. 156:149–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Le Blanc K, Rasmusson I, Sundberg B,
Götherström C, Hassan M, Uzunel M and Ringdén O: Treatment of
severe acute graft-versus-host disease with third party
haploidentical mesenchymal stem cells. Lancet. 363:1439–1441.
2004.PubMed/NCBI
|
|
18
|
Hoogduijn MJ, Popp FC, Grohnert A, Crop
MJ, van Rhijn M, Rowshani AT, Eggenhofer E, Renner P, Reinders ME,
Rabelink TJ, van der Laan LJ, Dor FJ, Ijzermans JN, Genever PG,
Lange C, Durrbach A, Houtgraaf JH, Christ B, Seifert M, Shagidulin
M, Donckier V, Deans R, Ringden O, Perico N, Remuzzi G, Bartholomew
A, Schlitt HJ, Weimar W, Baan CC and Dahlke MH; MISOT Study Group.
Advancement of mesenchymal stem cell therapy in solid organ
transplantation (MISOT). Transplantation. 90:124–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Le Blanc K, Frassoni F, Ball L, Locatelli
F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger
M, Dini G, Egeler RM, Bacigalupo A and Fibbe W; Ringdén O;
Development Committee of the Eurpoean Group for Blood and Marrow
Transplantation. Mesenchymal stem cells for treatment of
steroid-resistant, severe, acute graft-versus-host disease: a phase
II study. Lancet. 371:1579–1586. 2008.
|
|
20
|
Ciccocioppo R, Bernardo ME, Sgarella A,
Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A,
Calliada F, Dionigi P, Perotti C, Locatelli F and Corazza GR:
Autologous bone marrow-derived mesenchymal stromal cells in the
treatment of fistulising Crohn’s disease. Gut. 60:788–798.
2011.PubMed/NCBI
|
|
21
|
Tse WT, Pendleton JD, Beyer WM, Egalka MC
and Guinan EC: Suppression of allogeneic T-cell proliferation by
human marrow stromal cells: implications in transplantation.
Transplantation. 75:389–397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Melief SM, Zwaginga JJ, Fibbe WE and
Roelofs H: Adipose tissue-derived multipotent stromal cells have a
higher immunomodulatory capacity than their bone marrow-derived
counterparts. Stem Cells Transl Med. 2:455–463. 2013. View Article : Google Scholar
|
|
23
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kondoh N, Ishikawa T, Ohkura S, Arai M,
Hada A, Yamazaki Y, Kitagawa Y, Shindoh M, Takahashi M, Ando T,
Sato Y, Izumo T, Hitomi K and Yamamoto M: Gene expression
signatures that classify the mode of invasion of primary oral
squamous cell carcinomas. Mol Carcinog. 47:744–756. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lim JY, Park MJ, Im KI, Kim N, Jeon EJ,
Kim EJ, Cho ML and Cho SG: Combination cell therapy using
mesenchymal stem cells and regulatory T cells provides a
synergistic immunomodulatory effect associated with reciprocal
regulation of Th1/Th2 and Th17/Treg cells in a murine acute
graft-versus-host disease model. Cell Transplant. Feb 26–2013.(Epub
ahead of print).
|
|
26
|
Schroder K, Hertzog PJ, Ravasi T and Hume
DA: Interferon-gamma: an overview of signals, mechanisms and
functions. J Leukoc Biol. 75:163–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cambiaggi C, Scupoli MT, Cestari T, Gerosa
F, Carra G, Tridente G and Accolla RS: Constitutive expression of
CD69 in interspecies T-cell hybrids and locus assignment to human
chromosome 12. Immunogenetics. 36:117–120. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang HM, Sung JH, Choi YS, Lee HJ, Roh CR,
Kim J, Shin M, Song S, Kwon CH, Joh JW and Kim SJ: Enhancement of
the immunosuppressive effect of human adipose tissue-derived
mesenchymal stromal cells through HLA-G1 expression. Cytotherapy.
14:70–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nasef A, Mathieu N, Chapel A, Frick J,
François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D
and Fouillard L: Immunosuppressive effects of mesenchymal stem
cells: involvement of HLA-G. Transplantation. 84:231–237. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alberts B, Johnson A, Lewis J, Raff M,
Roberts K and Walter P: T cells and MHC proteins. Molecular biology
of the cell. 5th edition. Garland Science; New York, NY: pp.
1569–1588. 2008
|
|
31
|
Sato K, Ozaki K, Oh I, Meguro A, Hatanaka
K, Nagai T, Muroi K and Ozawa K: Nitric oxide plays a critical role
in suppression of T-cell proliferation by mesenchymal stem cells.
Blood. 109:228–234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang HM, Sung JH, Choi YS, Lee HJ, Roh CR,
Kim J, Shin M, Song S, Kwon CH, Joh JW and Kim SJ: Enhancement of
the immunosuppressive effect of human adipose tissue-derived
mesenchymal stromal cells through HLA-G1 expression. Cytotherapy.
14:70–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Musso A, Zocchi MR and Poggi A: Relevance
of the mevalonate biosynthetic pathway in the regulation of bone
marrow mesenchymal stromal cell-mediated effects on T-cell
proliferation and B-cell survival. Haematologica. 96:16–23. 2011.
View Article : Google Scholar : PubMed/NCBI
|
